Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by WaynerBob10 on Aug 03, 2021 1:42pm

Volume

Given the news and price drop is the volume of shares traded not much  lower than you would expect?
Comment by Harper75 on Aug 03, 2021 1:53pm
@WaynerBob10 - I was expecting much higher volume if the sky was indeed falling.  Obviously this news hurts but why not more panic selling by the weak retail hands??  Is it hope, delusion or is there more to this story...? I hope I'm not delusional - I think there is more to this story yet...
Comment by rixpix on Aug 03, 2021 3:42pm
100 times more volume so far than yesterday. I don't know how much more volume you'd need to see so you can call it panic selling.
Comment by Harper75 on Aug 03, 2021 3:50pm
IMO the panic selling ended shortly after open.  We've been bouncing around a dollar since 10am - with buyers taking every share offered.  
Comment by topadvisor1 on Aug 03, 2021 4:02pm
This post has been removed in accordance with Community Policy
Comment by SunsetGrill on Aug 03, 2021 4:10pm
Almost always afer a tramatic news event (such as ATE's) there is at least a THREE-Day sell off. Day 1 is now over.
Comment by mstrmnd on Aug 03, 2021 1:58pm
Buyers lining up at $1 mark  Panic sellers gone Rebound correction coming?
Comment by Bookworm28 on Aug 03, 2021 2:03pm
What do you figure? Is it time to put in a stink bid, or head for the hills? I'm a little tempted to put in a stink bid, but I can't see this turning around in the near term. It reminds me of BLU in 2020 when their results didn't pan out. They're taking another shot at it, but the stock hasn't recovered. Is ATE going to be allowed to sign anyone up for a phase iii trial?
Comment by WalkOverTheStrt on Aug 03, 2021 4:25pm
Bookworm  - instead of just throwing out silly questions without actual thoughts / data to back them (sounds like Tucker C) maybe it would be worth recalling that mgmt will need to perform analysis on the study and determine if there are any connections to those individuals drug use or past diease history. Rushing to judgement is well dumb... A similiar issue occurred in phase 1 but many are ...more  
Comment by Bookworm28 on Aug 03, 2021 6:35pm
WalkOverTheStrt - Thanks for the link from 6 years ago. The 2015 NRs make an interesting read. No clear explanation on what went wrong back then. They mention a much lower dose might make a difference.... which is what we have today. Probably not too much longer before things settle where they belong.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities